Stock screenerAll disclosures →
EDGAR →
NVCR
Conviction 66HealthcareScan · Thu, Jun 25, 2026NVCR$15.05+2.24%
ResistanceSupportVol 14Insider sell7
Vol MA14 1.79M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price15.05
Change+2.24%
Gap+0.14%
Rel volume0.95×
Avg volume1.73M
Avg $ vol28.03M
SMA 2016.45
SMA 5015.91
SMA 20013.40
Price vs 50-5.39%
Price vs 200+12.33%
MA stackmixed
50/200 cross—
Supertrenddown · 17.43
RSI (14)44
MACD hist-0.40
MACD cross—
Stoch %K / %D33 / 24
ADX (14)23
+DI / −DI19 / 30
RSI divergence—
MACD divergence—
ATR %+7.20%
ADR %5.99%
52w high18.46
52w low10.03
From 52w high-18.47%
Above 52w low+50.05%
New 52w highNo
SqueezeOff
Bollinger width32.64%
%B0.24
Donchian pos32.66%
Donchian high18.39
Donchian low13.43
AVWAP (52w high)16.80
vs AVWAP high-10.41%
AVWAP (52w low)13.95
vs AVWAP low+7.86%
OBV trendFlat
Chaikin MF (20)-0.15
Today vs 20d0.95×
Avg vol (14d)1.79M
Avg vol (20d)1.73M
Avg $ vol (20d)28.03M
Market cap1.74B
RS 3m (vs SPY)+17.32%
RS 6m (vs SPY)+6.91%
RS line new highNo
Trend template7/8
Technical rank57.2
1 week-15.69%
1 month-17.58%
3 months+29.63%
6 months+11.98%
1 year-11.47%
YTD+14.71%
P/E-12.80
P/B5.27
P/S2.66
P/FCF-23.03
EPS-1.22
Div yield—
ROE-41.19%
ROA-17.29%
Debt/Eq0.59
Current2.90
EV/EBITDA-13.30
Gross margin74.54%
Net margin-20.79%
Rev growth8.28%
EPS growth19.21%
Price target25.60
Target upside70.10%
Analyst ratingBuy
Institutional95.71%
Ent. value1.85B
Revenue174.06M
Net income-71.14M
Gross profit135.13M
Free cash flow-75.68M
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
ExchangeNasdaq
Shares out115.82M
Employees1.6K
ListedFri, Oct 2, 2015
Free float105.15M
Float %90.8%
Short interest9.15M
Days to cover6.9d
Short volume36.3%
Squeeze score42 / 100
Next earningsThu, Jul 23, 2026 (28d)
EPS forecast−$0.34 · 4 est
Last EPS vs est−$0.62 vs −$0.40
Last surprise-55.0% miss
Setup gradeB
Conviction66 / 100
Pattern quality—
Tech rank57.2 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance18.80
Support14.14
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NVCR
No recent disclosed trades by Congress in NVCR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NVCR · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Leonard Frank X Chief Executive Officer · Ordinary Shares · 2026-06-04 | Sell | 34.27K | $615K | 2026-06-04 | 2026-06-05 |
Ocean Allyson J Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 17K | $0 | 2026-06-03 | 2026-06-05 |
Madden Martin J. Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
HILLEMAN JERYL L Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
Scannell Timothy J Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 17K | $0 | 2026-06-03 | 2026-06-05 |
LEUNG GABRIEL Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
VERNON W ANTHONY Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
Stafford Kristin Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
VERNON W ANTHONY Director · Stock Option (Right to Buy) · 2026-06-03 | Grant | 17K | $0 | 2026-06-03 | 2026-06-05 |
Scannell Timothy J Director · Ordinary Shares · 2026-06-03 | Grant | 11.61K | $0 | 2026-06-03 | 2026-06-05 |
SEC filings
EDGAR filings in NVCR · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.